ISSN: 2559-5555
Digital ProScholar Media

Bogdan Popescu1,2, Irina Doinița Oașă1, Serban Vifor Gabriel Bertesteanu1,2, Cristian Balalau1,3, Felicia Manole4, Maria Domuta4, Alina Lavinia Antoaneta Oancea1,2

1CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY, BUCHAREST, ROMANIA
2COLTEA CLINICAL HOSPITAL, ENT DEPARTMENT, BUCHAREST, ROMANIA
3ST. PANTELIMON EMERGENCY HOSPITAL, DEPARTMENT OF GENERAL SURGERY, BUCHAREST, ROMANIA
4FACULTY OF MEDICINE AND PHARMACY, ORADEA, ROMANIA

Abstract

Solid tumors represent chronic disease that can be rarely detected, diagnosed and treated without the use of a multidisciplinary team. When a neoplastic disease is initially evaluated, involvement of a single physician does not seem to be sufficient to establish diagnosis and staging. Assessment of each individual case of malignancy is the main purpose of the entire medical staff engaged in treating cancer patients. In Romania, the use of oncology committee with a multidisciplinary form of organization has been set to work in Bucharest and Cluj-Napoca, since the beginning of 1978 under direct supervision of professors Alexandru Trestioreanu and Ion Chiricuță. The joint session of the tumor board resides into establishing the optimal oncology therapy for each patient. The task of informing the patient about the decision is performed by the physician that is overseeing the patients’ evolution. There is no mandatory oncology therapy action from behalf of the physician after the decision of the tumor board was made. However, it is more likely for head and neck cancer patients to receive better, more accurate staging, as well as optimal oncology therapy in a local or academic hospital tumor board setup.

Institutional e-repository